Loading company…
Zhejiang Sundoc develops complex injectable drugs using long-acting and targeted delivery technologies.
Founded in 2011 and based in Zhejiang, Sundoc develops complex injectable drugs using PLG microspheres, nanocrystallization, liposomes and lipid microspheres. Its research includes treatments for cancer, neuropsychiatric, endocrine and cardiovascular diseases; it was listed on China's National Equities Exchange and Quotations in 2015.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in